HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Ganglioglioma

Rare indolent tumors comprised of neoplastic glial and neuronal cells which occur primarily in children and young adults. Benign lesions tend to be associated with long survival unless the tumor degenerates into a histologically malignant form. They tend to occur in the optic nerve and white matter of the brain and spinal cord.
Also Known As:
Ganglioglioma, Benign; Ganglioglioma, Intracranial; Ganglioglioma, Malignant; Benign Ganglioglioma; Benign Gangliogliomas; Gangliogliomas; Gangliogliomas, Benign; Gangliogliomas, Intracranial; Gangliogliomas, Malignant; Intracranial Ganglioglioma; Intracranial Gangliogliomas; Malignant Ganglioglioma; Malignant Gangliogliomas
Networked: 191 relevant articles (3 outcomes, 20 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Pinealoma (Pineoblastoma)
2. Neoplasms (Cancer)
3. Neuroepithelial Neoplasms (Gliomatosis Cerebri)
4. Epilepsy (Aura)
5. Astrocytoma (Pilocytic Astrocytoma)

Experts

1. Aronica, E: 8 articles (02/2015 - 03/2001)
2. van Rijen, P C: 6 articles (02/2015 - 03/2001)
3. Troost, D: 6 articles (03/2007 - 03/2001)
4. Becker, Albert J: 5 articles (11/2008 - 10/2002)
5. Schramm, Johannes: 5 articles (01/2007 - 10/2002)
6. Elger, Christian E: 5 articles (01/2007 - 10/2002)
7. Leenstra, S: 5 articles (06/2005 - 03/2001)
8. Spliet, W G M: 4 articles (02/2015 - 06/2005)
9. Blümcke, Ingmar: 4 articles (11/2011 - 07/2002)
10. Majores, Michael: 4 articles (11/2008 - 11/2004)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Ganglioglioma:
1. Biological Tumor Markers (Tumor Markers)IBA
2. IodineIBA
3. 2,6-dinitrotoluene (DNT)IBA
4. DNA (Deoxyribonucleic Acid)IBA
5. SynaptophysinIBA
6. ParaffinIBA
7. Messenger RNA (mRNA)IBA
8. AntigensIBA
9. Androgen Receptors (Androgen Receptor)IBA
10. CollagenIBA

Therapies and Procedures

1. Radiotherapy
2. Brachytherapy
3. Craniotomy
4. Drug Therapy (Chemotherapy)
5. Ventriculoperitoneal Shunt